Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

347 Press Releases
DateTitleCompany
01 Sep 15 Teva Announces U.S. Availability of ZECUITY® (sumatriptan iontophoretic transdermal system), First and Only Transdermal Patch System for the Acute Treatment of Migraine Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
12 Aug 15 Teva Announces FDA Acceptance of NDA for SD-809 for Treatment in Huntington Disease Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
03 Aug 15 Teva and Immuneering Announce Teva’s Purchase of 51% Equity Share of Genomic-Analysis Company Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
31 Jul 15 Teva Secures $33.75 Billion Financing Commitment Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
28 Jul 15 Teva Announces European Medicines Agency (EMA) Confirms Successful Validation of Reslizumab Marketing Authorization Application Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
27 Jul 15 Teva Withdraws Proposal to Acquire Mylan Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
27 Jul 15 Teva Reports Preliminary Second Quarter 2015 Results Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
23 Jul 15 Teva Launches Educational Initiative to Arm Women with Facts about Emergency Contraception Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
23 Jul 15 Teva Issues Statement Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
21 Jul 15 Teva to Report Second Quarter 2015 Financial Results on July 30, 2015 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Jul 15 Teva First to Receive Approval and Launch Generic Axert® Tablets in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Jul 15 Teva and Xenon Provide Update on TV-45070 Phase 2b Study in Osteoarthritis Pain Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Jul 15 Teva Launches Generic Aggrenox® Capsules in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
25 Jun 15 Teva and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO Trial Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
19 Jun 15 Teva Completes the Purchase of 4.61 Percent Interest in Mylan N.V. Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
18 Jun 15 Teva to Present New Findings at the American Headache Society (AHS) Meeting – Analysis of Migraine Phase IIb Studies Provides Novel Insights into TEV-48125 Efficacy and Safety in Both Episodic & Chronic Migraine Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
18 Jun 15 Teva and Microchips Biotech Announce Partnership to Enhance Patient Outcomes through Digital Drug Delivery Technology Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
16 Jun 15 Teva Advances Pipeline of Movement Disorder Assets with Announcement of Positive Top-Line Data from the First Pivotal Study of Investigational Treatment for Patients with Tardive Dyskinesia Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 Jun 15 Teva Announces FDA Acceptance of the Biologics License Application for Reslizumab Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
09 Jun 15 Teva to Present at the Goldman Sachs 36th Annual Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
02 Jun 15 Teva Enhances ADHD Product Line with Generic INTUNIV® in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Jun 15 Teva Announces Exclusive Launch of Generic Actonel® Tablets in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
29 May 15 Teva Enhances Extensive Women’s Health Portfolio with Launch of Generic Lomedia® 24 Fe Tablets Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 May 15 Teva to Present New Respiratory Data at 2015 Annual International Meeting of the American Thoracic Society Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
14 May 15 Teva Presents Further Data from Phase IIb with TEV-48125 in Chronic Migraine at the International Headache Society Congress (IHC): Efficacy and Safety Results at All Doses and Endpoints Present Robust Case for Progression to Phase III Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 May 15 Teva to Present at the Bank of America Merrill Lynch 2015 Health Care Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
05 May 15 Teva Completes Acquisition of Auspex Pharmaceuticals Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
05 May 15 Teva Provides Additional Detail on Proposed Acquisition of Mylan Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
28 Apr 15 Teva Launches Generic Abilify® Tablets in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
28 Apr 15 Teva Continues to Invigorate Injectable Portfolio with the Launch of Argatroban Injection in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.